These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 16026734)

  • 1. Cytokines and signal transduction.
    Hideshima T; Podar K; Chauhan D; Anderson KC
    Best Pract Res Clin Haematol; 2005; 18(4):509-24. PubMed ID: 16026734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma.
    Yasui H; Hideshima T; Richardson PG; Anderson KC
    Br J Haematol; 2006 Feb; 132(4):385-97. PubMed ID: 16412014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor beta receptor I kinase inhibitor down-regulates cytokine secretion and multiple myeloma cell growth in the bone marrow microenvironment.
    Hayashi T; Hideshima T; Nguyen AN; Munoz O; Podar K; Hamasaki M; Ishitsuka K; Yasui H; Richardson P; Chakravarty S; Murphy A; Chauhan D; Higgins LS; Anderson KC
    Clin Cancer Res; 2004 Nov; 10(22):7540-6. PubMed ID: 15569984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MLN120B, a novel IkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo.
    Hideshima T; Neri P; Tassone P; Yasui H; Ishitsuka K; Raje N; Chauhan D; Podar K; Mitsiades C; Dang L; Munshi N; Richardson P; Schenkein D; Anderson KC
    Clin Cancer Res; 2006 Oct; 12(19):5887-94. PubMed ID: 17020997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
    Hatjiharissi E; Terpos E; Papaioannou M; Hatjileontis C; Kaloutsi V; Galaktidou G; Gerotziafas G; Christakis J; Zervas K
    Hematol Oncol; 2004 Dec; 22(4):159-68. PubMed ID: 15991268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Skeletal tissue response to cytokines.
    Goldring MB; Goldring SR
    Clin Orthop Relat Res; 1990 Sep; (258):245-78. PubMed ID: 2203572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of in vitro growth of multiple myeloma cells.
    Zlei M; Egert S; Wider D; Ihorst G; Wäsch R; Engelhardt M
    Exp Hematol; 2007 Oct; 35(10):1550-61. PubMed ID: 17889722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the vascular endothelial growth factor pathway in the treatment of multiple myeloma.
    Podar K; Richardson PG; Chauhan D; Anderson KC
    Expert Rev Anticancer Ther; 2007 Apr; 7(4):551-66. PubMed ID: 17428175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of B-cell-activating factor in adhesion and growth of human multiple myeloma cells in the bone marrow microenvironment.
    Tai YT; Li XF; Breitkreutz I; Song W; Neri P; Catley L; Podar K; Hideshima T; Chauhan D; Raje N; Schlossman R; Richardson P; Munshi NC; Anderson KC
    Cancer Res; 2006 Jul; 66(13):6675-82. PubMed ID: 16818641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of human and viral cytokines in the pathogenesis of multiple myeloma.
    Berenson JR; Sjak-Shie NN; Vescio RA
    Semin Cancer Biol; 2000 Oct; 10(5):383-91. PubMed ID: 11100886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro growth of human multiple myeloma: implications for biology and therapy.
    Caligaris-Cappio F; Gregoretti MG; Ghia P; Bergui L
    Hematol Oncol Clin North Am; 1992 Apr; 6(2):257-71. PubMed ID: 1582973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production.
    Markel TA; Crisostomo PR; Wang M; Herring CM; Meldrum DR
    Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G657-62. PubMed ID: 17640973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cytokines, growth factors, and metabolic bone disease].
    Pumarino H; Pumarino MG
    Rev Med Chil; 1996 Feb; 124(2):248-57. PubMed ID: 9213895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-18 induces angiogenic factors in rheumatoid arthritis synovial tissue fibroblasts via distinct signaling pathways.
    Amin MA; Mansfield PJ; Pakozdi A; Campbell PL; Ahmed S; Martinez RJ; Koch AE
    Arthritis Rheum; 2007 Jun; 56(6):1787-97. PubMed ID: 17530707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crucial role of phosphatase CD45 in determining signaling and proliferation of human myeloma cells.
    Collette M; Descamps G; Pellat-Deceunynck C; Bataille R; Amiot M
    Eur Cytokine Netw; 2007 Sep; 18(3):120-6. PubMed ID: 17823079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine and paracrine regulation by cytokines and growth factors in melanoma.
    Lázár-Molnár E; Hegyesi H; Tóth S; Falus A
    Cytokine; 2000 Jun; 12(6):547-54. PubMed ID: 10843728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiogenesis in multiple myeloma.
    Jakob C; Sterz J; Zavrski I; Heider U; Kleeberg L; Fleissner C; Kaiser M; Sezer O
    Eur J Cancer; 2006 Jul; 42(11):1581-90. PubMed ID: 16797965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 in multiple myeloma and related plasma cell dyscrasias.
    Treon SP; Anderson KC
    Curr Opin Hematol; 1998 Jan; 5(1):42-8. PubMed ID: 9515202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the biology of multiple myeloma: therapeutic applications.
    Anderson K
    Semin Oncol; 1999 Oct; 26(5 Suppl 13):10-22. PubMed ID: 10528890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of apoptosis in human multiple myeloma by insulin-like growth factor I (IGF-I).
    Jernberg-Wiklund H; Nilsson K
    Adv Cancer Res; 2007; 97():139-65. PubMed ID: 17419944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.